Povidone-iodine Prep Pad Solution
FDA Label NDC 63517-400

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 200, Inc. for the product Povidone-iodine Prep Pad (NDC 63517-400). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, purpose, use, warnings, do not use, ask a doctor before use if you have, stop use and consult a doctor, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient

Povidone-Iodine USP 10% (equivalent to 1% titratable iodine)

Purpose

First Aid Antiseptic

Use

•first aid to help prevent skin infection in minor cuts, scrapes, and burns

Warnings

For external use only. Allergy Alert: Do not apply to persons allergic to Iodine

Do Not Use

• in the eyes or apply over large areas of the body • longer than one week unless directed by a doctor

Ask A Doctor Before Use If You Have

• deep or puncture wounds • animal bites • serious burns

Stop Use And Consult A Doctor

if the condition persists or gets worse

Keep Out Of Reach Of Children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• clean the affected area • apply a small amount of this product on the area 1-3 times daily • may be covered with a sterile bandage • if bandaged, let dry first

Other Information

• store at 15°-30°C (59°-86°F)

Inactive Ingredients

(purified) water, glycerol, nonylphenol ethoxylate, citric acid, sodium hydroxide

Package Labeling:

Packet Labeling:

Packet Label (Pad)

Packet Label (Pad)

Box Labeling:

Box Label (Label)

Box Label (Label)

Carton Labeling:

Carton Labeling (Label2)

Carton Labeling (Label2)

* Please review the disclaimer below.